mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.7 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |